Charles River Laboratories Intl. Inc vs Enovix Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $282.01 (market cap $13.46B), while Enovix Corporation trades at $4.94 (market cap $1.06B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 12.7× Enovix Corporation's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| CRL | ENVX | |
|---|---|---|
Market Cap | $13.46B | $1.06B |
Sector | Health | Technology |
52-Week High | $282.00 | $13.19 |
52-Week Low | $145.57 | $3.68 |
Enterprise Value | $16.30B | $1.07B |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →